Cargando…
Study of LAT1 Expression in Brain Metastases: Towards a Better Understanding of the Results of Positron Emission Tomography Using Amino Acid Tracers
Positron emission tomography using radiolabeled amino acid (PET-AA) appears to be promising in distinguishing between recurrent tumour and radionecrosis in the follow-up of brain metastasis (BM). The amino acid transporter LAT1 and its cofactor CD98, which are involved in AA uptake, have never been...
Autores principales: | Papin-Michault, Caroline, Bonnetaud, Christelle, Dufour, Maxime, Almairac, Fabien, Coutts, Mickael, Patouraux, Stéphanie, Virolle, Thierry, Darcourt, Jacques, Burel-Vandenbos, Fanny |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4898730/ https://www.ncbi.nlm.nih.gov/pubmed/27276226 http://dx.doi.org/10.1371/journal.pone.0157139 |
Ejemplares similares
-
[18F] FDOPA standardized uptake values of brain tumors are not exclusively dependent on LAT1 expression
por: Dadone-Montaudié, Bérengère, et al.
Publicado: (2017) -
Cell-based therapy using miR-302-367 expressing cells represses glioblastoma growth
por: Fareh, Mohamed, et al.
Publicado: (2017) -
CELF2 Sustains a Proliferating/OLIG2+ Glioblastoma Cell Phenotype via the Epigenetic Repression of SOX3
por: Turchi, Laurent, et al.
Publicado: (2023) -
Glioblastoma cell motility depends on enhanced oxidative stress coupled with mobilization of a sulfurtransferase
por: Saurty-Seerunghen, Mirca S., et al.
Publicado: (2022) -
Apoptosis and pericyte loss in alveolar capillaries in COVID-19 infection: choice of markers matters. Author’s reply
por: Burel-Vandenbos, Fanny, et al.
Publicado: (2020)